Myriad Genetics, Angelina Jolie and Genomics in Focus
Myriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad's gene sequencing tested positive for the ...Read Full Story »



